Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma

[1]  Kwok-Kin Wong,et al.  Notch inhibition overcomes resistance to Tyrosine Kinase Inhibitors in EGFR-driven lung adenocarcinoma. , 2019, The Journal of clinical investigation.

[2]  M. Katoh,et al.  Precision medicine for human cancers with Notch signaling dysregulation (Review) , 2019, International journal of molecular medicine.

[3]  F. Kaye,et al.  Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer. , 2018, Journal of the National Cancer Institute.

[4]  F. Kaye,et al.  CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells , 2017, Oncogene.

[5]  T. Carey,et al.  Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma. , 2017, Oral oncology.

[6]  P. Meltzer,et al.  Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis). , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Ying Tang,et al.  Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequency , 2017, Science Translational Medicine.

[8]  J. Aster,et al.  The Varied Roles of Notch in Cancer. , 2017, Annual review of pathology.

[9]  R. Weber,et al.  Role of CRTC1/MAML2 Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma. , 2016, JAMA otolaryngology-- head & neck surgery.

[10]  J. Griffin,et al.  Gene expression profiling analysis of CRTC1-MAML2 fusion oncogene-induced transcriptional program in human mucoepidermoid carcinoma cells , 2015, BMC Cancer.

[11]  A. Pearson,et al.  ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas , 2015, Oncotarget.

[12]  Michael Kahn,et al.  Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update , 2015, Nature Reviews Clinical Oncology.

[13]  D. Carbone,et al.  EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling. , 2014, Cancer research.

[14]  F. Kaye,et al.  CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB–MYC involvement , 2014, Proceedings of the National Academy of Sciences.

[15]  J. Griffin,et al.  Aberrantly activated AREG–EGFR signaling is required for the growth and survival of CRTC1–MAML2 fusion-positive mucoepidermoid carcinoma cells , 2014, Oncogene.

[16]  Emma R. Andersson,et al.  Therapeutic modulation of Notch signalling — are we there yet? , 2014, Nature Reviews Drug Discovery.

[17]  F. Kaye,et al.  Characterization of tumorigenic cell lines from the recurrence and lymph node metastasis of a human salivary mucoepidermoid carcinoma. , 2013, Oral oncology.

[18]  H. Shen,et al.  DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia , 2013, Oncogene.

[19]  R. Coppes,et al.  Salisphere derived c-Kit+ cell transplantation restores tissue homeostasis in irradiated salivary gland. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  W. Pear,et al.  Brief Report: Blockade of Notch Signaling in Muscle Stem Cells Causes Muscular Dystrophic Phenotype and Impaired Muscle Regeneration , 2013, Stem cells.

[21]  S. Koyfman,et al.  Biology and management of salivary gland cancers. , 2012, Seminars in radiation oncology.

[22]  T. Golde,et al.  Notch signals in the endothelium and cancer "stem-like" cells: opportunities for cancer therapy , 2012, Vascular cell.

[23]  E. Hanna,et al.  Salivary Gland Cancers: Biology and Molecular Targets for Therapy , 2012, Current Oncology Reports.

[24]  J. Eveson.  Salivary tumours. , 2011, Periodontology 2000.

[25]  R. Coppes,et al.  Regeneration of irradiated salivary glands with stem cell marker expressing cells. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[27]  J. Reventós,et al.  Notch Pathway Inhibition Significantly Reduces Rhabdomyosarcoma Invasiveness and Mobility In Vitro , 2010, Clinical Cancer Research.

[28]  William Pao,et al.  Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer , 2010, Nature Reviews Cancer.

[29]  T. Golde,et al.  Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. , 2010, Anticancer research.

[30]  R. Seethala,et al.  A Reappraisal of the MECT1/MAML2 Translocation in Salivary Mucoepidermoid Carcinomas , 2010, The American journal of surgical pathology.

[31]  R. Coppes,et al.  Isolation and characterization of human salivary gland cells for stem cell transplantation to reduce radiation-induced hyposalivation. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  Raphael Kopan,et al.  The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.

[33]  I. Screpanti,et al.  The coactivator CRTC1 promotes cell proliferation and transformation via AP-1 , 2009, Proceedings of the National Academy of Sciences.

[34]  L. Wu,et al.  Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways , 2008, Oncogene.

[35]  L. Kowalski,et al.  Comparative Cytokeratin Expression in the Different Cell Types of Salivary Gland Mucoepidermoid Carcinoma , 2008, Head and neck pathology.

[36]  H. Kampinga,et al.  Rescue of Salivary Gland Function after Stem Cell Transplantation in Irradiated Glands , 2008, PloS one.

[37]  F. Radtke,et al.  Notch and cancer: a double-edged sword , 2008, Cellular and Molecular Life Sciences.

[38]  F. Radtke,et al.  Notch and cancer: a double-edged sword , 2007, Cellular and Molecular Life Sciences.

[39]  M. Bucci,et al.  Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy. , 2007, International journal of radiation oncology, biology, physics.

[40]  S. Chiba.  Concise Review: Notch Signaling in Stem Cell Systems , 2006 .

[41]  F. Kaye,et al.  Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation , 2006, Oncogene.

[42]  Daniel J. Hoeppner,et al.  Notch signalling regulates stem cell numbers in vitro and in vivo , 2006, Nature.

[43]  W. Pear,et al.  Impaired notch signaling promotes de novo squamous cell carcinoma formation. , 2006, Cancer research.

[44]  L. Szekely,et al.  Molecular classification of mucoepidermoid carcinomas—Prognostic significance of the MECT1–MAML2 fusion oncogene , 2006, Genes, chromosomes & cancer.

[45]  G. Collins.  The next generation. , 2006, Scientific American.

[46]  S. Chiba.  Notch signaling in stem cell systems. , 2006, Stem cells.

[47]  M. Sundaram,et al.  The love-hate relationship between Ras and Notch. , 2005, Genes & development.

[48]  F. Kaye,et al.  Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. , 2005, Cancer research.

[49]  J. Griffin,et al.  Transforming activity of MECT1‐MAML2 fusion oncoprotein is mediated by constitutive CREB activation , 2005, The EMBO journal.

[50]  Arie Perry,et al.  Notch1 and Notch2 Have Opposite Effects on Embryonal Brain Tumor Growth , 2004, Cancer Research.

[51]  David Allman,et al.  Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. , 2004, Blood.

[52]  Luiz Paulo Kowalski,et al.  Prognostic factors in head and neck mucoepidermoid carcinoma. , 2004, Archives of otolaryngology--head & neck surgery.

[53]  Gayle M. Smythe,et al.  Notch-Mediated Restoration of Regenerative Potential to Aged Muscle , 2003, Science.

[54]  Loren Miraglia,et al.  TORCs: transducers of regulated CREB activity. , 2003, Molecular cell.

[55]  G. Tonon,et al.  t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway , 2003, Nature Genetics.

[56]  James D. Griffin,et al.  Growth Suppression of Pre-T Acute Lymphoblastic Leukemia Cells by Inhibition of Notch Signaling , 2003, Molecular and Cellular Biology.

[57]  J. Aster,et al.  Notch Signaling in Cancer , 2002, Cancer biology & therapy.

[58]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[59]  S. Artavanis-Tsakonas,et al.  Notch Signaling : Cell Fate Control and Signal Integration in Development , 1999 .

[60]  P Bailey,et al.  Double Edged Sword , 2002 .

[61]  W. Breitbart,et al.  Clinical update , 1994, Psycho-oncology.

[62]  R. Weichselbaum,et al.  Chemotherapy of advanced salivary gland neoplasms , 1982, Cancer.

[63]  E. Gault,et al.  Salivary tumours. , 1951, The Indian journal of surgery.